Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
Department of Radiology, Saitama Cardiovascular and Respiratory Center, Saitama, Japan.
PLoS One. 2020 Apr 3;15(4):e0230746. doi: 10.1371/journal.pone.0230746. eCollection 2020.
The incidence and etiologies of chronic pulmonary infection (CPI) in patients with idiopathic pulmonary fibrosis (IPF) have been poorly investigated.
We conducted a retrospective study of 659 patients with IPF to assess the incidence, etiologies, and risk factors of CPI development. CPI was defined if the etiology of infection was diagnosed one or more months after the onset of symptoms or upon the appearance of new shadows on pulmonary radiological images.
At IPF diagnosis, 36 (5.5%) patients had CPI, and 46 (7.0%) patients without CPI at IPF diagnosis developed CPI over a median follow-up period of 6.1 years. The incidence density of CPI development was 18.90 cases per 1000 person-years. Detected organisms from these 46 patients were Mycobacterium avium complex in 20 patients, other nontuberculous mycobacteria in 4, M. tuberculosis in 7, Aspergillus spp. in 22, and Nocardia sp. in one. In a multivariate Cox regression hazard model, PaO2 <70 Torr and KL-6 ≥2000 U/mL were associated with CPI development.
Nontuberculous mycobacteria, M. tuberculosis, and Aspergillus and Nocardia spp. were the four most frequent etiologies of CPI in patients with IPF. During follow-up of IPF, clinicians should pay attention to the development of CPI, especially in patients with PaO2 <70 Torr or KL-6 ≥2000 U/mL.
特发性肺纤维化(IPF)患者慢性肺部感染(CPI)的发病率和病因学尚未得到充分研究。
我们对 659 例 IPF 患者进行了回顾性研究,以评估 CPI 发展的发病率、病因学和危险因素。如果感染的病因在症状出现后一个月或肺部放射影像学图像出现新阴影时被诊断出来,则定义为 CPI。
在 IPF 诊断时,36(5.5%)例患者患有 CPI,而在 IPF 诊断时无 CPI 的 46(7.0%)例患者在中位随访 6.1 年后发展为 CPI。CPI 发展的发病率密度为 18.90 例/1000 人年。从这 46 例患者中检出的病原体包括 20 例鸟分枝杆菌复合体、4 例非结核分枝杆菌、7 例结核分枝杆菌、22 例曲霉菌属和 1 例诺卡氏菌属。在多变量 Cox 回归风险模型中,PaO2 <70 Torr 和 KL-6 ≥2000 U/mL 与 CPI 发展相关。
非结核分枝杆菌、结核分枝杆菌以及曲霉菌属和诺卡氏菌属是 IPF 患者 CPI 的四种最常见病因。在 IPF 的随访期间,临床医生应注意 CPI 的发展,尤其是在 PaO2 <70 Torr 或 KL-6 ≥2000 U/mL 的患者中。